on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation. .
-
., an emerita professor in the department of food science & technology at uc davis.
.
-
.: "fremanezumab for the preventive treatment of chronic migraine."